Kiniksa Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 10,292 | 0.0137% |
| VC/PE Firms | 3,879,426 | 5.18% |
| Individual Insiders | 5,378,610 | 7.18% |
| Hedge Funds | 31,827,540 | 42.5% |
| Institutions | 33,830,981 | 45.2% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 31,827,540 | US$563.1m | 0.56% | 7.15% | |||
| 4,192,446 | US$74.2m | 31.8% | no data | |||
| 3,879,426 | US$68.6m | -22.3% | 0.42% | |||
| 3,225,136 | US$57.1m | 82% | no data | |||
| 2,965,299 | US$52.5m | 0.21% | no data | |||
| 2,907,501 | US$51.4m | -5.52% | 1.69% | |||
| 2,883,221 | US$51.0m | 16.5% | 5.79% | |||
| 1,692,606 | US$29.9m | 14.5% | no data | |||
| 1,570,816 | US$27.8m | -2.11% | 0.02% | |||
| 1,546,096 | US$27.4m | -12.2% | no data | |||
| 1,511,120 | US$26.7m | 14.7% | no data | |||
| 789,261 | US$14.0m | 0% | 0.84% | |||
| 722,388 | US$12.8m | 35.2% | 0.45% | |||
| 714,879 | US$12.6m | -5.98% | 0.14% | |||
| 699,613 | US$12.4m | 6.07% | no data | |||
| 661,715 | US$11.7m | 31.4% | 0.09% | |||
| 618,798 | US$10.9m | -2.71% | 0.66% | |||
| 615,693 | US$10.9m | 20.8% | 1.51% | |||
| 600,000 | US$10.6m | 0% | 1.2% | |||
| 557,620 | US$9.9m | -8.58% | no data | |||
| 456,041 | US$8.1m | 0% | 6.19% | |||
| 428,335 | US$7.6m | -29.3% | 0.01% | |||
| 409,831 | US$7.3m | -27.3% | no data | |||
| 351,592 | US$6.2m | 37.4% | no data | |||
| 349,753 | US$6.2m | -6.41% | no data |